On-bright Electronics (shanghai) Co., Ltd.

Huawei Technologies Co., Limited

Sunshine Lake Pharma Co., Ltd.

Weihua Wang

Lieyi Fang

Yuan Lin

Zhiqiang Sun

Zheng Gu

Xiuhong Zhang

Chunhui Le

Jianyu Liu

Jianhao Li

Xinshan Deng

Haoxiong Qin

Ning Yang

Yingjun Zhang

Senbao Guo

Huafeng Lin

Ying Zhang

Wuyong Wu

Panpan Kang

Yuanmou Li

Zheng Li

Xuli Wang

An OLT performs interactive authentication with an optical module, and determines a time sequence parameter of the optical module. The optical module stores the time sequence parameter in a register of the optical module. When the optical module is inserted into the OLT and is in a working state, the OLT reads the time sequence parameter stored in the optical module. Then, based on the time sequence parameter, the OLT determines and configures time sequence information of an ONU corresponding to the optical module.

Time sequence information configuration method and related apparatus

At present relates to a glucopyranosyl derivative and application thereof. In particular, relates to a glucopyranosyl derivative as a sodium-dependent glucose transporters1 (SGLT1) inhibitor, and a pharmaceutically acceptable salt or a stereoisomer thereof, and further relates to a pharmaceutical composition containing the derivative. Further relating to uses of the compound and pharmaceutical composition thereof in the preparation of drugs for the treatment of diabetes and diabetes-related diseases.

Glucopyranosyl derivatives and their uses

An isoquinolinone compound acts as an inhibitor of semicarbazide-sensitive oxidase (SSAO) and/or vascular adhesion protein-1 (VAP-1), and the use thereof, and further relates to a pharmaceutical composition containing the compound. The compound or the pharmaceutical composition can be used to prepare a drug for preventing, treating or ameliorating inflammation and/or inflammation-related diseases, diabetes and/or diabetes-related diseases in patients, and especially can be used to prepare a drug for preventing, treating or ameliorating non-alcoholic fatty liver diseases in patients.

Isoquinolinone compound for inhibiting ssao/vap-1, and use thereof

Embodiments of this application disclose a user pairing method and a related device. The method includes: determining a first generation parameter of a first base sequence of a first user and a second generation parameter of a second base sequence of a second user, and the second base sequence is used to generate a second uplink reference signal of the second user; determining multiplexing evaluation information based on the first generation parameter and the second generation parameter, where the multiplexing evaluation information may include correlation strength between sequences and interference leakage width; determining, based on the multiplexing evaluation information, whether the first user and the second user are successfully paired; and determining, that the first user and the second user multiplex a same communication resource for communication based on being successfully paired.

User pairing method and related device

This application discloses a channel estimation method and apparatus. When time-domain channel estimation is performed on a first slot, the first slot and at least one second slot are first determined. The first slot and each second slot form continuous slots. Then, a first signal corresponding to the first slot and a second signal corresponding to each second slot are obtained, and a time-domain channel estimate for the first slot is determined based on the first signal and each second signal. In embodiments of this application, when a time-domain channel estimate for a specific slot is determined, time-domain channel estimation is performed by using time-domain correlation of channels in combination with signals of a plurality of slots, so as to obtain a more accurate channel estimation result, thereby improving baseband demodulation performance.

Channel estimation method and apparatus

An amine compound serving as a semicarbazide-sensitive amine oxidase (SSAO) and/or vascular adhesion protein-1 (VAP-1) inhibitor, a pharmaceutical composition, and an application thereof in medicines that can be used for treating inflammation and/or inflammation related diseases, diabetes and/or a disease related diabetes, psychiatric disorder, ischemic disease, vascular disease, fibrosis, or tissue transplant rejection.

Amine compound for inhibiting SSAO/VAP-1 and use thereof

System and method for regulating an output of a power conversion system. An example system controller includes a signal generator and a modulation and drive component. The signal generator is configured to receive at least a first signal indicating a magnitude of an input voltage received by a primary winding of a power conversion system and receive a second signal indicating a magnitude of a primary current flowing through the primary winding, and generate a third signal. The modulation and drive component is configured to receive at least the third signal, generate a drive signal based on at least information associated with the third signal, and output the drive signal to a switch to affect the primary current.

Systems and methods for peak current adjustments in power conversion systems

Systems and methods are provided for voltage regulation of power conversion systems. An example system controller includes: a first sampling component configured to sample a sensing signal and determine a compensation signal based on at least in part on the sensing signal, the sensing signal being associated with a first current flowing through a primary winding of a power conversion system; a signal processing component configured to receive a feedback signal and the compensation signal and generate a first signal based at least in part on the feedback signal and the compensation signal, the feedback signal being associated with an auxiliary winding coupled with a secondary winding of the power conversion system; an error amplifier configured to receive the first signal and a reference signal and generate an amplified signal based at least in part on the first signal and the reference signal.

Systems and methods for voltage regulation of primary side regulated power conversion systems with compensation mechanisms

Growing community of inventors

Shanghai, China

Weihua Wang